FORWARD‐LOOKING STATEMENTS
FORWARD‐LOOKING STATEMENTS
Certain statements in this presentation may constitute “forward‐looking” statements that involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company, or industry results, to be materially different from any future results, performance or achievements expressed or implied by such forward‐looking statements. The Company disclaims any intention or obligation to update or revise any forward forward‐ looking statements, whether as a result of new information, future events or otherwise, other than as required by law.
2
ATRIUM OVERVIEW
ATRIUM OVERVIEW
•
•
Strong commitment to product development and improvements
Strong commitment to product development and improvements –
Innovation Science Committee with over 15 PhDs, MDs, nutritionists
& dieticians
•
Multi‐channel sales/distribution strategy:
Multi channel sales/distribution strategy:
– Healthcare practitioners
– Health food and specialized stores
– Direct‐to‐consumer
Direct to consumer
•
Seven GMP compliant manufacturing facilities
•
3
Extensive portfolio of best‐in‐class, science‐based and professionally endorsed dietary supplements primarily sold in North America and
Europe
g p $
Strategic and disciplined consolidator in $US80 billion+ worldwide industry Atrium s Mission
Atrium’s Mission
Grow. In Health.
G
I H lth
•
•
Atrium owns and develops unique individual business units that are dedicated to the promotion of health and well‐being
•
4
Atrium is committed to supporting optimal health through innovative science‐based products and services science based products and services
Atrium is proud to operate a vibrant family of premium brands
FINANCIAL PERFORMANCE – 5 YEARS
FINANCIAL PERFORMANCE – 5 YEARS
2009
2005
CAGR
319.7
319 7
32.9
32 9
76.6%
76 6%
EBITDA
80.8
10.5
66.6%
Net Earnings
48.7
5.8
70.2%
$1.47
$0.20
64.7%
53.9
9.5
54.3%
(US$ Millions)
Revenues
EPS
Cash Flow before WC
7
CONVERGENCE – ATRIUM IS WELL POSTIONED
CONVERGENCE – ATRIUM IS WELL POSTIONED
Systemic movement from “disease care” to “preventive care” preventive care systems worldwide
8
Medicine
Nutrition
COMPLEMENTARY TO HEALTH & NUTRITION
COMPLEMENTARY TO HEALTH & NUTRITION
Preventive Health for
Current Pandemics
Diabetes
Reduced
Stress
Exercise
Dietary
Supplements
Diet
9
Obesity
Heart
ea t
Disease
Cancer
Consumers
• Growth in aging population
• T d t
Trends toward h lth li i d healthy living
• Self-care a d se educat o
Se ca e and self-education
• Alternative and/or complement to drugs • Soaring cost of drugs and healthcare 10
Medical Establishment Endorsement
• Growing support of medical community
• Part of the education of MDs
• More scientific evidence supporting industry • 80% of doctors/nurses use supplements
11
Governments
• H lh
Healthcare reforms worldwide f ld id
• Soaring cost of healthcare system and g y the role of preventive medicine
• Increased regulation worldwide
12
DIETARY SUPPLEMENT SALES – BY CHANNEL
DIETARY SUPPLEMENT SALES – BY CHANNEL
2009 U.S.
Supplement
Sales
$7.8
Chapter 4 Financial Statement Analysis Tools Introduction You’ve studied ratio analysis several times in your financial studies. This chapter demonstrates how to set up ratios in Excel. The process is straight-forward. It involves typing the ratio formulas into Excel and pulling the data for the calculations for the related financial statements. Review of Ratios This week's discussion focuses on financial indicators or ratios that we use to gain further insight into company performance. Financial ratios…
Guidelines for Preparation of a Financial Analysis 1. Gather information: a. Background information on the company i. Company website ii. 10-K and 10-Q reports iii. Stock price trends and analysts opinions (available on Yahoo Finance)) b. Background information on the industry i. Yahoo Finance ii. Internet search c. Background information on the general economy i. Data from Federal…
The financial landscape during and after Enron Enron appeared to be a company on the rise in the 1990’s and into the new century. However, in 2001, the world was shocked by the demise of Enron, a multibillion dollar corporation that had thousands of employees and people that had affiliations with the company including The White House itself. Because of the financial chaos and destroyed lives and reputations this catastrophe left in its path, questions arose concerning how exactly it happened, why…
LUBS 3865 FINANCIAL ANALYSIS SESSION 2 OVERVIEW OF FINANCIAL ANALYSIS Objectives To introduce the framework that will be use in the module to evaluate company performance Introduction The framework adopted for evaluating the performance of a company focuses on three interrelated aspects of a firm’s performance: 1. its strategic direction 2. its financial statement performance 3 its stock market performance An analysis of a company’s performance requires a thorough evaluation of these three…
Financial Statement Analysis Candice R. Lambert ACC/230 May 26, 2013 Darcie Sargent Financial Statement Analysis I choose Lowes as my company to complete my financial analysis. The financial statement I chose to use was Lowes annual 10-K report. The first weakness I found in this report is the overwhelming amount of information. Someone with no background in financial reports may have no idea what they are looking at. Another down fall is all the information in this report. There are 15…
Financial analysis (ratios) Subject: Accounting Below are the relevant and significant ratios of Novarties and Merck companies. These are both in the pharmaceutical industry and health care products. Novarties Merck Profitability ratios 2012 2011 2012 2011 Net profit margin 18.64% 18.99% 13.05% 13.05% Return on stockholders' equity 15% 14% 11% 9% Earnings per share 3.86 1.67 Gross profit rate 72.87% 72.64% 65.21% 64.89% Price/Earnings ratio 19.79 28.74 Liquidity ratios:…
SPARTECH Corporation 2009 2010 Industry Average Current Ratio 1.6 times 1.5 times 2.26 Quick Ratio 0.88 times 0.85 times 0.87 Average collection period 51 days 48 days 13 days Days inventory held 28 days 31 days 134 days Days payable outstanding 47 days 52 days 37 days Cash Conversion Cycle…
CVS and Walgreens are part of the drug store industry. They sell prescription drugs and other products such as over-the-counter medications, health products, food, and other home products. Walgreens and CVS have many stores that draw customers to them because they are able to fill prescription medications for consumers. “The larger drug store chains typically generate about 70 percent of their sales from prescriptions; front-end items account for 30 percent. The number of front-store items has…
